Magnesium Sulfate
Treatment for Maternal hypertensive disorders
Typical Dosage: 4-6 g IV loading dose, then 1-2 g/hour infusion
Effectiveness
95%
Safety Score
58%
Clinical Trials
1
Participants
20K
Comparative Safety Scale(Higher is safer)
Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
58
DangerousModerateSafe
Treatment Details
Dosage Range
4-6 g IV loading dose, then 1-2 g/hour infusion
Time to Effect
immediate (IV)
Treatment Duration
24 hours post-delivery or post-seizure
Evidence Quality
HIGHNumber Needed to Treat (NNT)
18(Treat 18 patients to see 1 additional successful outcome)
Confidence Score
95%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$0
Monitoring:$1,200
Side Effect Mgmt:$0
Total Annual:$1,200
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENTQALYs Gained
0.8
Magnesium Sulfate Outcomes
for Maternal hypertensive disorders
Efficacy Outcomes
Overall Effectiveness
+95%
Response Rate
+90%
Common Side Effects
Flushing
+15%
Warmth
+15%
Nausea
+7%
Headache
+7%
Muscle weakness
+5%
Respiratory depression
+0.5%
Sources:
WARNING: LIMITED TRIALS AVAILABLE
You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!
Active Clinical Trials
No active trials currently recruiting for this treatment
No active trials found in ClinicalTrials.gov
Completed Clinical Trials
1 completed trial for Magnesium Sulfate in Maternal hypertensive disorders
Risk Analysis of Intensive Care Mangement on Maternal and Fetal Outcome of Severe Preeclampsia and Eclampsia
NCT03412552COMPLETED
1.24K participants
OBSERVATIONAL
Cairo, Egypt
Started: Oct 1, 2015